LONDON, Sept. 10, 2025 (Korea Bizwire) — In a historic step toward positioning Saudi Arabia as a global hub for biotechnology, Sarat Ventures Y Innovations Biotech Fund (UK) announced today the launch of a biotech fund, anchored by Allocator One, anticipated to invest roughly $50M in biotech companies with strategic connections to the Saudi Arabian [...]
Partnership brings Leap’s total investment to a quarter billion dollars – advancing toward a $1 billion goal to transform outcomes for women worldwide SAN DIEGO, Sept. 10, 2025 (Korea Bizwire) — Wellcome Leap, a U.S. non-profit, and Pivotal, a group of organizations founded by Melinda French Gates, today announced a $100 million partnership to accelerate [...]
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) is a different kind of global biopharmaceutical leader, one that operates across the full spectrum of innovation to reliably deliver medicines to patients worldwide. (Image from Teva webpage) Teva received Fast Track designation from the U.S. Food and Drug Administration for emrusolmin (TEV-56286), an investigational treatment for [...]
SHANGHAI, Sept. 07, 2025 (Korea Bizwire) – Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced that company’s product, recombinant humanized anti-IL-17A monoclonal antibody (code: JS005) has achieved positive results in a multi-center, randomized, double-blind, parallel, placebo-controlled [...]
MILAN, Sept. 05, 2025 (Korea Bizwire) – AAVantgarde Bio (AAVantgarde), a clinical-stage biotechnology company developing next-generation gene therapies for inherited retinal diseases, today announced the presentation of updated clinical data from the LUCE-1 study at the 25th European Society of Retina Specialists (EURETINA) Annual Congress (EURetina 2025), taking place in Paris 4-7 September 2025. Data presented by Prof. [...]
BioTrack Capital and Yonjin Capital join Series A round alongside other investors including 3E Bioventures Capital, Proxima Ventures Ltd., and Lapam Capital Upsized and over-subscribed Series A total funding of $44 million secured Rapafusyn’s RapaGlue™ platform rapidly discovers non-degrading molecular glues, a validated and highly sought-after modality to address challenging disease targets BALTIMORE, MD, Sept. [...]
BILTHOVEN, Netherlands and BOSTON, Sept. 04, 2025 (Korea Bizwire) – Avania, the leading global MedTech advisory and clinical development partner, is pleased to announce strategic leadership appointments of four distinguished executives. As the MedTech industry navigates increasing regulatory complexity and technological innovation, these new leaders bring decades of combined experience in clinical research, regulatory affairs, operations, [...]
New Preprint: PridCor Therapeutics LLC has released a pre-print detailing a case series of 15 patients with Long COVID (LC) who were given a continuous regimen of 120-days of valacyclovir and celecoxib with a pulsed 15-day treatment of Paxlovid (combination antiviral treatment, or CAR), and these patients were compared to 12 patients with Long COVID who [...]
New global clinical insights initiative debuts at World Sleep Congress 2025 to help drive innovation in sleep health care SAN DIEGO, Sept. 03, 2025 (Korea Bizwire) – Resmed (NYSE: RMD, ASX: RMD), the leading health technology company focused on sleep, breathing, and care delivered in the home, today announced the launch of Sleep Institute, a global [...]
Collaboration combines AI imaging, diagnostics expertise, and clinical leadership to drive digital pathology forward WALTHAM, Mass. and ERLANGEN, Germany and LUDWIGSHAFEN, Germany, Sept. 03, 2025 (Korea Bizwire) – Siemens Healthineers, a leading global medical technology company, and Evident — which recently acquired Pramana, an AI-enabled health tech company modernizing the pathology sector — announced a [...]